Drug Topics

JUNE 22, 2023

A study found that pharmacists possessed moderate to low knowledge scores when it came to statements tackling biosimilars.

469

469

PharmaVoice

JUNE 22, 2023

These six Big Pharma companies have ranked among the best places to work for LGTBQ+ equality by the Human Rights Campaign Foundation for over 10 years. Here’s why.

246

246

Drug Topics

JUNE 22, 2023

The Act4Biosimilars Action Plan aims to highlight key challenges preventing patient access to biosimilars and outline steps to help overcome them.

458

458

PhRMA

JUNE 22, 2023

Research doesn’t end once a medicine is first approved by the U.S. Food and Drug Administration (FDA). Researchers often spend years after an initial approval exploring and obtaining approval of new indications for medicines to treat other patient populations desperate for new treatment options. Patients with cancer or rare diseases often depend on this post-approval research.

FDA 146

FDA 146

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JUNE 22, 2023

In a large observational study, significant information was obtained about mRNA vaccine protection against acute infection and disease severity.

Vaccines 247

Vaccines 247

Pharmacy Times

JUNE 22, 2023

Pharmacists play key roles in performing comprehensive patient reviews, reducing polypharmacy.

144

144

Pharmacy Times

JUNE 22, 2023

Treatment with lisocabtagene maraleucel led to strong and durable response rates with little serious adverse effects in patients with relapsed or refractory follicular lymphoma and mantle cell lymphoma.

139

139

Fierce Healthcare

JUNE 22, 2023

Ochsner Health and The University of Texas MD Anderson Cancer Center are partnering to build an integrated cancer care program in southeastern Louisiana, the organizations announced Thursday. | The first phase of the new collaboration will see cancer patients at seven of Ochsner's southeast Louisiana facilities become eligible for breaking clinical trials.

130

130

Pharmacy Times

JUNE 22, 2023

Utilizing longitudinal assessments of language impairment and clinical progression could help identify challenges earlier.

132

132

PharmaVoice

JUNE 22, 2023

Marwan Fathallah came onboard earlier this year to lead the organization into an era of change.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 22, 2023

The Act4Biosimilars Action Plan highlights major challengers in preventing access to biosimilars and actionable steps to accelerate the adoption by overcoming these challenges.

123

123

STAT

JUNE 22, 2023

When I was diagnosed with Duchenne muscular dystrophy 20 years ago, there was no hope. The guidance the diagnosing doctor gave my parents was simple: Love your child as much as you can now because he won’t be here very long. That was the inspiration that my mom needed to start CureDuchenne. Her intention — our whole family’s intention — was to cure this disease so no other parents would have to go through the same traumatic prognosis.

FDA 123

FDA 123

Pharmacy Times

JUNE 22, 2023

As part of the approval condition, the FDA is requiring Sarepta Therapeutics to complete a clinical study to confirm the drug’s benefit in motor and physical functions.

FDA 123

FDA 123

pharmaphorum

JUNE 22, 2023

Swiss hospital adopts Bayer’s AI platform for radiology Phil.

Hospitals 122

Hospitals 122

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 22, 2023

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Sandra Leal, PharmD, MPH, FAPhA, CDCES, vice president of pharmacy practice innovation and advocacy at CVS Pharmacy, to discuss how pharmacists are diving into public health and expanding their roles.

123

123

Fierce Pharma

JUNE 22, 2023

Even after second application attempt, Intercept’s Ocaliva wasn’t the fatty liver disease breakthrough that the company had hoped it would be. | Even after second application attempt, Intercept’s Ocaliva wasn’t the fatty liver disease breakthrough that the company had hoped it would be. Intercept is now swinging into restructuring mode, and the NASH baton passes on to Madrigal Pharma.

FDA 121

FDA 121

Pharmacy Times

JUNE 22, 2023

Health Mart is offering a new basic training program with ASHP/ACPE accreditation for pharmacy technicians, along with accredited and non-accredited training.

123

123

STAT

JUNE 22, 2023

For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans. Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JUNE 22, 2023

The approval was based on data from 2 studies of blinatumomab in adults and pediatric patients with CD19-positive B-cell precursor acute lymphoblastic leukemia.

FDA 123

FDA 123

Fierce Pharma

JUNE 22, 2023

The EMA is scrutinizing GLP-1s, raising a safety signal about the risk that drugs from Novo Nordisk, Eli Lilly and other companies could cause cancer.

108

108

Pharmacy Times

JUNE 22, 2023

Six-month preexposure prophylaxis (PrEP) dispensing supported by HIV self-testing resulted in PrEP adherence after 12 months and less visits to clinical sites.

122

122

STAT

JUNE 22, 2023

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use. The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.

FDA 106

FDA 106

Pharmacy Times

JUNE 22, 2023

Extended use of an N95 mask in daily life can cause various cardiopulmonary stresses, such as reduced respiration, elevated heart rate and blood pressure, and increased energy expenditure.

122

122

Fierce Healthcare

JUNE 22, 2023

The Boys & Girls Clubs of America (BGCA) is on the front lines of battling the youth mental health crisis, and it's securing reinforcements in the form of a $10 million grant from the Blue Cros | The Blue Cross Blue Shield Association hopes that its $10 million grant to the Boys & Girls Clubs of America will play a part in addressing the mental health crisis facing America’s youth.

105

105

pharmaphorum

JUNE 22, 2023

CDC panel backs use of GSK, Pfizer’s RSV shots this year Phil.

105

105

Drug Store News

JUNE 22, 2023

Target and Walmart are following Amazon's lead in kicking off summer sales promotions.

105

105

STAT

JUNE 22, 2023

Pfizer announced last week that it expects to run out of a key drug for treating syphilis in the near future — a looming problem that health professionals say could exacerbate syphilis rates, widen racial disparities in sexually transmitted diseases, and stymie global access to the antibiotic, especially within lower-income countries. The drug in question is Bicillin, an injectable, long-acting form of penicillin most commonly used to treat syphilis in adults as well as childhood infectio

104

104

Hospital Pharmacy Europe

JUNE 22, 2023

An electronic prescribing (EP) system within an intensive care unit (ICU) requires a lower level of clinical pharmacist input compared to a paper-based system, according to a recent prospective, longitudinal UK study. Although EP systems are designed to reduce medication errors , the quality of evidence on their effectiveness is variable. Nevertheless, within an ICU setting, the use of commercial computerised provider order entry systems led to an 85% reduction in medication prescribing error ra

Patient Care 104

Patient Care Hospitals 104

Drug Store News

JUNE 22, 2023

​​​​​​​Foster & Thrive is intended to help meet the evolving needs and growing demand for quality, over-the counter private-label health and wellness products.

Labelling 104

Labelling 104

STAT

JUNE 22, 2023

The number of people with diabetes worldwide is set to more than double to 1.3 billion by 2050, a new study finds, a trend accelerated by widening inequities both between and within countries. By 2050, about 1 in 10 people around the world are predicted to have the disease, representing a 60% surge in the prevalence of diabetes, according to the study, published Thursday in the Lancet as part of a wide-ranging series on global inequities in diabetes.

103

103

Pharmaceutical Technology

JUNE 22, 2023

Eli Lilly and Boehringer Ingelheim have received approval from the US FDA for Jardiance to treat type 2 diabetes in children

FDA 98

FDA 98

STAT

JUNE 22, 2023

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people. The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday.

FDA 103

FDA 103

Pharmaceutical Technology

JUNE 22, 2023

The SFDA of the KSA has granted approval to Amarin’s VASCEPA (icosapent ethyl) capsules for reducing cardiovascular risk.

98

98